Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,108 | 66,791 | 81,584 | 122,170 | 28,020 |
| Marketable Securities | 217,781 | 237,819 | 252,408 | 237,603 | 173,023 |
| Receivables | 970 | 527 | 434 | 679 | 427 |
| TOTAL | $294,936 | $309,256 | $339,541 | $364,129 | $204,985 |
| Non-Current Assets | |||||
| PPE Net | 11,461 | 11,864 | 11,735 | 11,236 | 10,535 |
| Intangibles | 29,759 | 30,012 | 30,265 | 30,519 | 30,772 |
| Other Non-Current Assets | 1,428 | 1,500 | 1,676 | 1,816 | 1,722 |
| TOTAL | $42,648 | $43,376 | $43,676 | $43,571 | $43,029 |
| Total Assets | $337,584 | $352,632 | $383,217 | $407,700 | $248,014 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,795 | 2,792 | 2,657 | N/A |
| Accounts payable and accrued liabilities | 1,506 | 1,217 | 2,020 | 3,071 | 2,603 |
| Accrued Expenses | 24,316 | 19,623 | 21,879 | 15,420 | 19,296 |
| Other current liabilities | 4,418 | N/A | N/A | N/A | 2,592 |
| TOTAL | $30,240 | $23,635 | $26,691 | $21,148 | $24,491 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 17,239 | 10,370 | 10,648 | 11,000 | 11,863 |
| TOTAL | $17,239 | $10,370 | $10,648 | $11,000 | $11,863 |
| Total Liabilities | $47,479 | $34,005 | $37,339 | $32,148 | $36,354 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,584 | 6,580 | 6,576 | 6,569 | 5,977 |
| Common Shares | 99 | 99 | 99 | 98 | 90 |
| Retained earnings | -590,956 | -558,272 | -526,292 | -493,933 | -463,759 |
| Other shareholders' equity | 2,307 | 2,560 | 2,436 | 2,616 | 2,590 |
| TOTAL | $290,105 | $318,627 | $345,878 | $375,552 | $211,660 |
| Total Liabilities And Equity | $337,584 | $352,632 | $383,217 | $407,700 | $248,014 |